Literature DB >> 17963908

Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.

Piet Dirix1, Sandra Nuyts, Bianca Vanstraelen, An Nulens, Robert Hermans, Mark Jorissen, Vincent Vander Poorten, Walter Van den Bogaert.   

Abstract

PURPOSE: To evaluate the clinical outcome and toxicity of post-operative intensity-modulated radiotherapy (IMRT) for malignancies of the nasal cavity and paranasal sinuses. METHODS AND MATERIALS: Twenty-five patients with histological proven cancer of the paranasal sinuses (n=21) or nasal cavity (n=4) were post-operatively treated with IMRT at the Leuven department to a total dose of 60 Gy (n=15) or 66 Gy (n=10). Both acute and chronic toxicity were prospectively scored in all patients.
RESULTS: Median follow-up was 27 months (range: 12-47 months) among surviving patients. The actuarial 2-year local control (LC), overall survival (OS) and disease-free survival (DFS) rates were 81%, 88% and 77%, respectively. One patient developed isolated distant metastasis, while none of the patients developed regional failure. No grade 3 or 4 toxicity was reported, either acute or chronic. No radiation-induced blindness or brain necrosis was reported to date, although longer follow-up has to be awaited for definitive results.
CONCLUSION: Post-operative IMRT for sinonasal cancer resulted in similar local control and survival rates as conventional or 3D-conformal radiotherapy techniques, and was associated with little acute toxicity. Longer follow-up is necessary to confirm the lack of late complications.

Entities:  

Mesh:

Year:  2007        PMID: 17963908     DOI: 10.1016/j.radonc.2007.10.001

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.

Authors:  S A Bhide; K L Newbold; K J Harrington; C M Nutting
Journal:  Br J Radiol       Date:  2012-05       Impact factor: 3.039

2.  Locally advanced paranasal sinus carcinoma: A study of 30 patients.

Authors:  Francesco Perri; Raffaele Addeo; Manuel Conson; Adriana Faiella; Giuseppina Della Vittoria Scarpati; Gabriella Torre; Angela Di Biase; Paola Romanelli; Carlo Buonerba; Giuseppe Di Lorenzo; Antonio Daponte; Francesco Caponigro; Salvatore Pisconti; Roberto Pacelli; Vincenzo Ravo; Paolo Muto; Raffaele Solla
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

3.  Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study.

Authors:  Shucheng Bi; Jie Li; Tongyu Wang; Fengyuan Man; Peng Zhang; Feng Hou; Hexiang Wang; Dapeng Hao
Journal:  Eur Radiol       Date:  2022-06-10       Impact factor: 7.034

4.  [Principles of radiation therapy for malignant tumors of the orbit and the periorbital area].

Authors:  T Kuhnt; M Janich
Journal:  HNO       Date:  2010-01       Impact factor: 1.284

5.  Sinonasal malignancies and charged particle radiation treatment: a systematic literature review.

Authors:  Marco Cianchetti; Maurizio Amichetti
Journal:  Int J Otolaryngol       Date:  2012-05-27

6.  Radiooncological View on Therapy Outcome after Multidisciplinary Treatment of Sinonasal Tumors.

Authors:  Olena Klymenko; Anna Maria Stefanie Buchberger; Barbara Wollenberg; Klaus-Dietrich Wolff; Victoria Kehl; Stephanie E Combs; Anja Pickhard; Steffi U Pigorsch
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

7.  Loosening Neuro-Optic Structures Dosimetric Constraints Provides High 5-Year Local Recurrence-Free Survival With Acceptable Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy.

Authors:  Tingting Zhang; Meng Xu; Jinglin Mi; Hui Yang; Zhengchun Liu; Lulu Huang; Kai Hu; Rensheng Wang
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.